![Hina Waheed Chaudhry](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hina Waheed Chaudhry
Corporate Officer/Principal chez
Icahn School of Medicine at Mount Sinai
Profil
Hina Waheed Chaudhry was the founder of VentriNova, Inc. which was founded in 2006 where she held the title of Chief Scientific Officer.
Currently, she is the Director of Cardiovascular Regenerative Medicine at Icahn School of Medicine at Mount Sinai.
Dr. Chaudhry has an undergraduate degree from Massachusetts Institute of Technology and a doctorate degree from Harvard Medical School.
Postes actifs de Hina Waheed Chaudhry
| Sociétés | Poste | Début |
|---|---|---|
Icahn School of Medicine at Mount Sinai
 Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Hina Waheed Chaudhry
| Sociétés | Poste | Fin |
|---|---|---|
VentriNova, Inc.
 VentriNova, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy for the regeneration of heart tissue in patients with heart failure and after myocardial infarction | Fondateur | - |
Formation de Hina Waheed Chaudhry
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
28
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VentriNova, Inc.
VentriNova, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy for the regeneration of heart tissue in patients with heart failure and after myocardial infarction | Health Technology |
Choisissez Zonebourse 
